Among the various mechanisms contributing to the MDR phenotype in cancer, a significant factor is the high expression of ATP-binding cassette (ABC) drug transporters, particularly ABCB1 (P-glycoprotein/MDR1) and ABCG2 (BCRP/MXR/ABCP). Here, ABCB1 is linked to cancer.